The US Political Landscape: What impact will it have on the biotech industry?

BioFuture 2024

Increasing The Stakes: Creating and Selling Your Valuation Story in Changing Times

Biotech CEO Summit USA 2024

Biotech CEO Summit 2024

2024: WHAT’S ON THE HORIZON? Reflections, Projections and Earnest Hopes

Extending the Runway: Tactics and Strategies to Emerge on the Other Side as a Healthier Company

Derek Brand Interviews Nessan Bermingham at BioFuture 2023

Virginia Amann Interviews Jennifer Hawks Bland at BioFuture 2023

Zegbeh Jallah Interviews Beth Rogozinski at BioFuture 2023

David Ewing Duncan Interviews Timothy Peters-Strickland at BioFuture 2023

Steve Brozak Interviews Rick Bright at BioFuture 2023

Virginia Amann Interviews Brent Vaughan at BioFuture 2023

Querida Anderson Interviews Vincent Beltrani & Eric Elenko at BioFuture 2023

Sara Jane Demy Interviews Brad Sitko at BioFuture 2023

Jay Campbell Interviews Mani Mohindru at BioFuture 2023

Jeremy Abbate Interviews Timothy Cooke at BioFuture 2023

Jeremy Abbate Interviews Gloria Caulfield at BioFuture 2023

Walter Greenleaf Interviews JoAnn Difede & Mark Edwards at BioFuture2023

Sara Jane Demy interviews Nick Shipley at BioFuture 2023

David Ewing Duncan interviews Nouhad Husseini & Dennis Purcell at BioFuture 2023

Jeremy Abbate interviews Susan Rosenthal at BioFuture 2023

Seema Kumar Interviews Andy Plump at BioFuture 2023

Exploring Solid Tumor Treatment at its Core: A conversation with prominent KOLs

VC Trends in Healthcare Investing: Current Pulse Check

Envisioning The Future of Healthcare- The Big4Bio Podcast

Beyond CAR-T, What's Next for Cell Therapy

Reimagine The Future of Healthcare at BioFuture 2023!

Part 3 of 3: Future-Proofing: How to Prepare a Value-Based Market Access Strategy

Part 2 of 3: Making It Real: What Does an Early-Stage Market Access Strategy Look Like?